Obesity pharmacotherapy in older adults: a narrative review of evidence International Journal of Obesity Retatrutide vs. Tirzepatide: The Next Gen GLP 1 Showdown Tirzepatide: a new low for bodyweight and blood glucose The Lancet Diabetes & Endocrinology Cagrilintide, an amylin analogue, is a promising medication for weight loss by enhancing satiety, delaying gastric emptying, and suppressing appetite. In my patients, I have also seen increased New Developments in Pharmacological Treatment of Obesity and Type 2 DiabetesBeyond and within GLP 1 Receptor Agonists